Delivery Order SPE2DR25D1109-SPE2DR26FFF6N
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $11,174.80 for 100-unit vials of Xeomin, a botulinum toxin product used for therapeutic and cosmetic medical applications. This non-set-aside, competitively awarded contract employs firm fixed pricing and is scheduled for completion by November 17, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,587.40 for 100-unit vials of Xeomin, a botulinum toxin product used for therapeutic and cosmetic applications. This non-set-aside, firm fixed-price delivery order was awarded on October 30, 2025, with an ultimate completion date of November 21, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $49,461.72 delivery order to AmerisourceBergen Drug Corp for 200-unit vials of Xeomin, a botulinum toxin product used for therapeutic and cosmetic applications. This firm fixed-price contract, awarded November 5, 2025, with completion targeted for November 28, 2025, represents a competitively awarded procurement with no set-aside designation. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company...
- The Defense Logistics Agency awarded a $5,888.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100-unit vials of Xeomin, a botulinum toxin product used for therapeutic and cosmetic medical applications. The contract, issued on November 13, 2025, with completion targeted for December 5, 2025, represents a non-competitive set-aside delivery against AmerisourceBergen's larger pharmaceutical supply agreement. This award will be performed at the contractor's corporate office...
- The Defense Logistics Agency awarded a $22,349.60 firm fixed price delivery order to AmerisourceBergen Drug Corp for 200-unit vials of Xeomin, a botulinum toxin product used for medical and therapeutic purposes. This non-set-aside contract, issued on August 14, 2025, with an ultimate completion date of September 5, 2025, represents a routine pharmaceutical supply transaction fulfilling federal medical procurement needs. The award is being performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $1,396.85 delivery order to AmerisourceBergen Drug Corp for 100-unit vials of Xeomin, a botulinum toxin product used for therapeutic and cosmetic medical applications. This firm fixed price delivery order, issued on July 24, 2025, with an ultimate completion date of August 14, 2025, will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This...
- The Defense Logistics Agency awarded a delivery order valued at $26.8K to AmerisourceBergen Drug Corp for 200-unit vials of Xeomin, a botulinum toxin product used for therapeutic and cosmetic medical applications. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure, with an ultimate completion date of November 7, 2025. Performance will be executed from AmerisourceBergen's headquarters location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of 200-unit vials of Xeomin, a botulinum toxin product used for therapeutic and cosmetic applications. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $5,888.30 and is scheduled for completion by November 13, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,793.70 to AmerisourceBergen Drug Corp for 100-unit vials of Xeomin, a botulinum toxin product used for therapeutic and cosmetic purposes. Issued on September 26, 2025, with an ultimate completion date of October 20, 2025, this firm fixed-price delivery order represents a competitively awarded, non-set-aside contract. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $8,381.10 to AmerisourceBergen Drug Corp for 100-unit vials of Xeomin, a botulinum toxin-based therapeutic product used for medical applications. This non-set-aside, competitively awarded contract is issued under a firm fixed price structure with an ultimate completion date of September 19, 2025. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate...
- SPE2DR25D1109Indefinite Delivery Contract
- SPE2DR25D1109-SPE2DR26FFF6NDelivery Order
The Defense Logistics Agency awarded a $11,776.60 delivery order to AmerisourceBergen Drug Corp for 200-unit vials of Xeomin, a botulinum toxin preparation used for therapeutic and cosmetic medical applications. This firm fixed price contract, issued on October 27, 2025, with an ultimate completion date of November 18, 2025, represents a competitive award with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's substantial $999.999 billion Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which runs through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a vast range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. Through this flexible contracting arrangement, AmerisourceBergen supports critical federal healthcare customers including the Defense Health Agency and U.S. Coast Guard, positioning the company as a key pharmaceutical distributor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.8k | 10/27/25 |